X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
abridged index medicus (3) 3
cancer (3) 3
chemotherapy (3) 3
index medicus (3) 3
internal medicine (3) 3
medicine, general & internal (3) 3
aged (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
cancer therapies (2) 2
carboplatin (2) 2
clinical trials (2) 2
combination (2) 2
female (2) 2
humans (2) 2
lung neoplasms - drug therapy (2) 2
lung neoplasms - mortality (2) 2
male (2) 2
radiation therapy (2) 2
1st-line therapy (1) 1
adenocarcinoma (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
age (1) 1
aged, 80 and over (1) 1
analysis (1) 1
angiogenesis inhibitors (1) 1
antineoplastic agents (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
bevacizumab - administration & dosage (1) 1
bevacizumab - adverse effects (1) 1
blood (1) 1
carboplatin - administration & dosage (1) 1
carboplatin - adverse effects (1) 1
carcinoma, non-small-cell lung (1) 1
carcinoma, non-small-cell lung - drug therapy (1) 1
carcinoma, non-small-cell lung - mortality (1) 1
carcinoma, squamous cell (1) 1
carcinoma, squamous cell - drug therapy (1) 1
carcinoma, squamous cell - mortality (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
cisplatin - adverse effects (1) 1
comorbidity (1) 1
creatinine - blood (1) 1
crizotinib (1) 1
deoxycytidine (1) 1
deoxycytidine - administration & dosage (1) 1
deoxycytidine - analogs & derivatives (1) 1
drug administration schedule (1) 1
endothelial growth factors (1) 1
endothelial growth-factor (1) 1
endothelium (1) 1
fluorouracil (1) 1
genomics (1) 1
geriatric-oncology (1) 1
hypertension - epidemiology (1) 1
international-society (1) 1
legislators (1) 1
life sciences (1) 1
lung cancer (1) 1
lung cancer, non-small cell (1) 1
lung neoplasms (1) 1
lung neoplasms - pathology (1) 1
lymphomas (1) 1
malignant mesothelioma (1) 1
management (1) 1
medical prognosis (1) 1
mesothelioma (1) 1
mesothelioma - drug therapy (1) 1
mesothelioma - mortality (1) 1
mesothelioma - pathology (1) 1
metastasis (1) 1
middle aged (1) 1
mitogens (1) 1
multicenter (1) 1
neutropenia (1) 1
older (1) 1
paclitaxel (1) 1
paclitaxel - administration & dosage (1) 1
paclitaxel - adverse effects (1) 1
pain (1) 1
paramount (1) 1
patients (1) 1
pemetrexed - administration & dosage (1) 1
pemetrexed - adverse effects (1) 1
pemetrexed plus cisplatin (1) 1
pleural neoplasms - drug therapy (1) 1
pleural neoplasms - mortality (1) 1
pleural neoplasms - pathology (1) 1
plus bevacizumab (1) 1
population (1) 1
product development (1) 1
prognostic-factors (1) 1
proteinuria - epidemiology (1) 1
quality-of-life (1) 1
survival (1) 1
survival rate (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 387, Issue 10026, pp. 1405 - 1414
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9796, pp. 1079 - 1088
Summary Background Platinum-based doublet chemotherapy is recommended to treat advanced non-small-cell lung cancer (NSCLC) in fit, non-elderly adults, but... 
Internal Medicine | GERIATRIC-ONCOLOGY | SURVIVAL | POPULATION | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | INTERNATIONAL-SOCIETY | OLDER | QUALITY-OF-LIFE | COMBINATION | AGE | COMORBIDITY | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Carboplatin - adverse effects | Carcinoma, Squamous Cell - mortality | Vinblastine - analogs & derivatives | Antineoplastic Agents - adverse effects | Aged, 80 and over | Female | Paclitaxel - administration & dosage | Drug Administration Schedule | Deoxycytidine - administration & dosage | Carboplatin - administration & dosage | Paclitaxel - adverse effects | Survival Rate | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Clinical trials | Chemotherapy | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus | Adenocarcinoma | Vinblastine | Carcinoma, Non-Small-Cell Lung | Antineoplastic Agents | Antineoplastic Combined Chemotherapy Protocols | Lung Neoplasms | Carcinoma, Squamous Cell | Life Sciences | Deoxycytidine | Paclitaxel | Carboplatin | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.